cbdMD, Inc. (YCBD) Gross margin 2016–2025
cbdMD, Inc. (YCBD) gross margin by fiscal year — reported gross profit divided by reported revenue.
62.4%FY2025 · since FY2016: 20.3% → 62.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 62.4% | +0.8 pp |
| FY2024 | 61.6% | -0.4 pp |
| FY2023 | 62.0% | -1.1 pp |
| FY2022 | 63.1% | -4.3 pp |
| FY2021 | 67.4% | +4.5 pp |
| FY2020 | 63.0% | +1.6 pp |
| FY2019 | 61.4% | -16.0 pp |
| FY2018 | 77.3% | +7.6 pp |
| FY2017 | 69.7% | +49.4 pp |
| FY2016 | 20.3% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More YCBD financial trends
YCBD RevenueYCBD Net incomeYCBD Net marginYCBD Gross profitYCBD Operating incomeYCBD Operating marginYCBD Operating cash flowYCBD Free cash flowYCBD Capital expendituresYCBD Return on equityYCBD Stock buybacksYCBD Dividends paidYCBD Total assetsYCBD Total liabilitiesYCBD Shareholders’ equityYCBD overview →